Background: In 1997, a national standardized surveillance system for nosocomial infections (NI) in surgery patients was established in Spain. This system, known as the VICONOS program, is based on the US National Nosocomial Infection Surveillance System (NNISS). Herein, we present a summary of the data collected from January 1997 to December 2003.

Methods: VICONOS actively monitors all patients referred to the surgery ward of each participating hospital. The criteria used to define surgical site infection (SSI), patient risk index category, and surgical procedures used are those established by the Centers for Disease Control and Prevention (CDC) and the NNISS.

Results: SSI rates are shown by operative procedure and NNISS risk index category. Standardized infection ratios (SIR) were calculated for the 7 surgical procedures most frequently performed to compare our rates with those published by the NNISS. We provide factors that can be used as quality indicators such as rates of main surgery complications, length of hospital stay, and presurgery prophylaxis. Also described are the most used antimicrobial agents, the microorganisms most frequently isolated, and the corresponding sites.

Conclusion: VICONOS counts on the voluntary participation of 43 Spanish public hospitals. Our immediate plans are to incorporate new surveillance components and encourage new centers to join our network.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajic.2005.10.004DOI Listing

Publication Analysis

Top Keywords

national nosocomial
8
nosocomial infection
8
infection surveillance
8
surgery patients
8
january 1997
8
1997 december
8
surveillance system
8
risk category
8
surgical procedures
8
spanish national
4

Similar Publications

Neglected class A carbapenemases: Systematic review of IMI/NmcA and FRI from a One Health perspective.

Sci Total Environ

January 2025

Laboratoire de Bactériologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France; UMR MIVEGEC, Université de Montpellier, IRD, CNRS, Montpellier, France.

Carbapenemase-producing Enterobacterales are pathogens classified as a critical priority by the World Health Organization and a burden on human health worldwide. IMI, NmcA, and FRI are under-detected class A carbapenemases that have been reported in the human, animal and environmental compartments, particularly these last 5 years. Bacteria producing these carbapenemases have been mostly identified in digestive carriage screenings, but they are also involved in severe infections, such as bacteremia.

View Article and Find Full Text PDF

Molecular epidemiology of carbapenem-resistant group in Taiwan.

mSphere

December 2024

Department of Microbiology and Immunology, School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.

particularly the group, is a major cause of nosocomial infections, and carbapenem-resistant spp. are important human pathogens. We collected 492 spp.

View Article and Find Full Text PDF

Pseudomonas aeruginosa is a hard-to-treat human pathogen for which new antimicrobial agents are urgently needed. P. aeruginosa is known for forming biofilms, a complex aggregate of bacteria embedded in a self-generated protective matrix that enhance its resistance to antibiotics and the immune system.

View Article and Find Full Text PDF

Background: Pseudomonas aeruginosa is one of the leading causes of nosocomial infections and the most common multidrug-resistant pathogen. This study aimed to determine antimicrobial resistance patterns, biofilm-forming capacity, and associated factors of multidrug resistance in P. aeruginosa isolates at two hospitals in Addis Ababa, Ethiopia.

View Article and Find Full Text PDF

We report a case of Acanthamoeba infection in an HCT recipient with steroid-refractory GVHD. We highlight the multiple challenges that free-living ameba infections present to the clinician, the clinical laboratory, transplant infectious disease for review, hospital epidemiology if nosocomial transmission is considered, and public health officials, as exposure source identification can be a significant challenge. Transplant physicians should include Acanthamoeba infections in their differential diagnosis of a patient with skin, sinus, lung, and/or brain involvement.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!